C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells (Q38965179)

8 September 2017

title

C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells (English)

1 reference

8 September 2017

1 reference

Chengyao Xie

1

1 reference

8 September 2017

Yongqi Pan

2

1 reference

8 September 2017

Fengxia Hao

3

1 reference

8 September 2017

Yuan Gao

4

1 reference

8 September 2017

Zan Liu

5

1 reference

8 September 2017

Xiuwei Zhang

6

1 reference

8 September 2017

Lingling Xie

7

1 reference

8 September 2017

Guiyang Jiang

8

1 reference

8 September 2017

Qingchang Li

9

1 reference

8 September 2017

Enhua Wang

10

1 reference

8 September 2017

publication date

6 August 2014

1 reference

Acta Pathologica et Microbiologica Scandinavica

8 September 2017

published in

1 reference

8 September 2017

volume

122

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

1251-1258

1 reference

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway

8 September 2017

cites work

1 reference

Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells.

21 January 2018

1 reference

Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.

21 January 2018

1 reference

c-MYC, PARP1 and BIN1 as targets for therapy of cancer cell resistance

21 January 2018

1 reference

Prognostic factors in human primary breast cancer: comparison of c-myc and HER2/neu amplification

21 January 2018

1 reference

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

21 January 2018

1 reference

Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis

21 January 2018

1 reference

Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array

21 January 2018

1 reference

Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer

21 January 2018

1 reference

c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells

21 January 2018

1 reference

Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.

21 January 2018

1 reference

The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma

21 January 2018

1 reference

Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model

21 January 2018

1 reference

Targeting oncogenes to improve breast cancer chemotherapy

21 January 2018

1 reference

Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo

21 January 2018

1 reference

siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells

21 January 2018

1 reference

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

21 January 2018

1 reference

Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells

21 January 2018

1 reference

c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL

21 January 2018

1 reference

c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling

21 January 2018

1 reference

c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle

21 January 2018

1 reference

RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells

21 January 2018

1 reference

c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APM.12296

1 reference

8 September 2017

1 reference